Barclays Maintains Overweight on Nutrien, Lowers Price Target to $78

Benzinga Newsdesk www.benzinga.com Negative 80.4%

Neg 80.4% Neu 0% Pos 0%

Barclays analyst Benjamin Theurer maintains Nutrien (NYSE:NTR) with a Overweight and lowers the price target from $81 to $78.